American Renal Associates (ARA) Misses Q4 EPS by 2c

American Renal Associates (NYSE: ARA) reported Q4 EPS of $0.26, $0.02 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $19.1 million versus the consensus estimate of $197.98 million.

• Net patient service operating revenues increased 14% to $199.1 million;
• Net income (loss) attributable to American Renal Associates Holdings, Inc. was $(7.1) million or $(0.02) per share as compared to $6.8 million or $0.30 per share in Q4 2015;
• Adjusted EBITDA less noncontrolling interests (“Adjusted EBITDA-NCI”) increased 3.4% to $32.2 million;
• Adjusted net income attributable to American Renal Associates Holdings, Inc. was $8.7 million or $0.26 per share for the fourth quarter of 2016;
• Total dialysis treatments increased 11.4%, of which 10.3% was non-acquired growth (“NAG”); and
• As of December 31, 2016, the Company operated 214 outpatient dialysis centers serving approximately 14,500 patients.

For earnings history and earnings-related data on American Renal Associates (ARA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c